SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001267602-22-000020
Filing Date
2022-05-09
Accepted
2022-05-09 08:40:51
Documents
14
Period of Report
2022-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alim-20220509x8k.htm   iXBRL 8-K 76226
2 EX-99.1 alim-20220509xex99_1.htm EX-99.1 155325
3 GRAPHIC alim-20220509xex99_1g001.jpg GRAPHIC 55720
  Complete submission text file 0001267602-22-000020.txt   449733

Data Files

Seq Description Document Type Size
4 EX-101.SCH alim-20220509.xsd EX-101.SCH 2338
5 EX-101.LAB alim-20220509_lab.xml EX-101.LAB 19880
6 EX-101.PRE alim-20220509_pre.xml EX-101.PRE 11128
8 EXTRACTED XBRL INSTANCE DOCUMENT alim-20220509x8k_htm.xml XML 4767
Mailing Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005
Business Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34703 | Film No.: 22903399
SIC: 2834 Pharmaceutical Preparations